USP30 and oral cavity squamous cell carcinoma: For example, the use of nano delivery systems to deliver USP30 inhibitors, as demonstrated in oral squamous cell carcinoma, could improve the therapeutic efficacy by enhancing the delivery and targeting of inhibitors to cancer cells (Zhang X. et al., 2022).